Lei Huo

10PUBLICATIONS

75CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyMolecular targetsComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|May 08, 2026

FOXA1 is a highly sensitive diagnostic marker for prostate cancer including small cell carcinoma of the prostate.

|Dec 18, 2025

Imaging- and Tumor Biomarker-Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer.

Beatriz E Adrada, Mary S Guirguis, Lei Huo

|Nov 20, 2025

Early tumor volume reduction by breast DCE MRI predicts pathologic complete response to neoadjuvant therapy in triple negative breast cancer.

Mary S Guirguis, Beatriz E Adrada, Clinton Yam

|Aug 13, 2025

An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy.

Amanda L Rinkenbaugh, Yuan Qi, Shirong Cai

|Oct 02, 2024

Targeting the Epidermal Growth Factor Receptor Pathway in Chemotherapy-Resistant Triple-Negative Breast Cancer: A Phase II Study.

Clinton Yam, Miral Patel, Holly A Hill

|Mar 14, 2024

Comprehensive Analysis Identifies Variability in PI3K Pathway Alterations in Triple-Negative Breast Cancer Subtypes.

Reva K Basho, Li Zhao, Jason B White

Pageof 2

Frequent Collaborators

Debu Tripathy

Gaiane M Rauch

Banu K Arun

Jason White

Naoto Ueno

Clinton Yam

Bora Lim

Jennifer Litton

Senthil Damodaran

Roland L Bassett

Frequent Collaborators

Debu Tripathy

Gaiane M Rauch

Banu K Arun

Jason White